MOLECULAR PREDICTORS OF RESPONSE TO SELINEXOR IN RECURRENT GLIOBLASTOMA (GBM)

被引：0

作者：

Walker, Christopher ^{[1
]}

Shen, Yao ^{[2
]}

Mau-Soerensen, Morten ^{[3
]}

Wen, Patrick ^{[4
]}

van den Bent, Martin ^{[5
]}

Plotkin, Scott ^{[6
]}

Walenkamp, Annemiek ^{[7
]}

Green, Adam ^{[8
]}

Califano, Andrea ^{[2
]}

Chang, Hua ^{[1
]}

Tamir, Sharon ^{[1
]}

Henegar, Leah ^{[1
]}

Shacham, Sharon ^{[1
]}

Alvarez, Mariano ^{[2
]}

Landesman, Yosef ^{[1
]}

Lassman, Andrew ^{[9
]}

机构：

[1] Karyopharm Therapeut Inc, Newton, MA USA

[2] Darwin Hlth, New York, NY USA

[3] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Erasmus MC Canc Inst, Rotterdam, Netherlands

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Univ Groningen, Groningen, Netherlands

[8] Univ Colorado, Aurora, CO USA

[9] Columbia Univ, New York Presbyterian Hosp, Irving Med Ctr, New York, NY USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BIOM-26

引用

页码：7 / 7

页数：1

共 50 条

[1] Molecular predictors of response to selinexor in recurrent glioblastoma (GBM).
Walker, Christopher James
Shen, Yao
Mau-Sorensen, Morten
Wen, Patrick Y.
Van den Bent, Martin J.
Plotkin, Scott Randall
Walenkamp, Anna Maria Elisabeth
Green, Adam
Califano, Andrea
Chang, Hua
Henegar, Leah
Shacham, Sharon
Alvarez, Mariano J.
Landesman, Yosef
Lassman, Andrew B.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[2] EFFICACY AND SAFETY OF SELINEXOR IN RECURRENT GLIOBLASTOMA
Lassman, A. B.
Wen, P. Y.
van den Bent, M.
Plotkin, S. R.
Walenkamp, A.
Green, A.
Huang, X.
Rodriguez-Lopez, K. Karla
Kauffman, M. G.
Shacham, S.
Mau-Soerensen, M.
NEURO-ONCOLOGY, 2019, 21 : 3 - 4
[3] Efficacy and Safety of Selinexor in Recurrent Glioblastoma
Lassman, A. B.
Wen, P. Y.
van den Bent, M.
Plotkin, S. R.
Walenkamp, A.
Green, A.
Huang, X.
Rodriguez-Lopez, K. Karla
Kauffman, M. G.
Shacham, S.
Mau-Soerensen, M.
NEUROTHERAPEUTICS, 2020, 17 (03) : 1315 - 1316
[4] IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)
Schaff, Lauren R.
Lassman, Andrew B.
Goldlust, Samuel A.
Cloughesy, Timothy
Singer, Samuel
Schwartz, Gary K.
Iwamoto, Fabio M.
NEURO-ONCOLOGY, 2014, 16
[5] Efficacy and safety of selinexor in recurrent glioblastoma.
Lassman, Andrew B.
Wen, Patrick Y.
Van den Bent, Martin J.
Plotkin, Scott Randall
Walenkamp, Anna Maria Elisabeth
Huang, Xiu
Rodriguez-Lopez, Karla
Kauffman, Michael G.
Shacham, Sharon
Mau-Sorensen, Morten
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[6] STEREOTACTIC RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA (GBM)
Anselmo, P.
Maranzano, E.
Casale, M.
Trippa, F.
Italiani, M.
Rossi, R.
Di Palma, A.
Chirico, L.
Basagni, M. L.
Giorgi, C.
RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S272 - S272
[7] A phase 2 study on efficacy, safety and intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM).
Lassen, Ulrik Niels
Mau-Soerensen, Morten
Kung, Andrew L.
Wen, Patrick Y.
Lee, Eudocia Quant
Plotkin, Scott R.
Muhic, Aida
Rashal, Tami
Williams, Tony
McCauley, Dilara
Ellis, Joel
Saint-Martin, Jean-Richard
Carlson, Robert
Frenkel, Ran
Shacham, Sharon
Mirza, Mansoor Raza
Kauffman, Michael
Lassman, Andrew B.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[8] Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
Silvia Chiesa
Antonella Mangraviti
Maurizio Martini
Tonia Cenci
Ciro Mazzarella
Simona Gaudino
Serena Bracci
Antonella Martino
Giuseppe M. Della Pepa
Martina Offi
Marco Gessi
Rosellina Russo
Matia Martucci
Francesco Beghella Bartoli
Luigi M. Larocca
Liverana Lauretti
Alessandro Olivi
Roberto Pallini
Mario Balducci
Quintino Giorgio D’Alessandris
Scientific Reports, 12
[9] Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
Chiesa, Silvia
Mangraviti, Antonella
Martini, Maurizio
Cenci, Tonia
Mazzarella, Ciro
Gaudino, Simona
Bracci, Serena
Martino, Antonella
Della Pepa, Giuseppe M.
Offi, Martina
Gessi, Marco
Russo, Rosellina
Martucci, Matia
Bartoli, Francesco Beghella
Larocca, Luigi M.
Lauretti, Liverana
Olivi, Alessandro
Pallini, Roberto
Balducci, Mario
D'Alessandris, Quintino Giorgio
SCIENTIFIC REPORTS, 2022, 12 (01)
[10] A phase 2 study on efficacy, safety and intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM).
Mau-Sorensen, Morten
Plotkin, Scott Randall
Wen, Patrick Y.
Kung, Andrew L.
Lassen, Ulrik Niels
Saint-Martin, Jean-Richard
Wright, Greg
Chudnovsky, Aleksander
Ellis, Joel
Friedlander, Sharon
van Eijk, Bert
Shacham, Sharon
Kauffman, Michael G.
Lassman, Andrew B.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

← 1 2 3 4 5 →